Clinical Guides
Obesity: Assessment, Long-Term Care and Specialist Treatment
An India-contextualised, source-grounded guide to respectful adult obesity assessment, sustained health-focused care, and carefully governed escalation to medicines or metabolic surgery.
MedNext Academy | 13 min read
Obesity: Assessment, Long-Term Care and Specialist Treatment
An India-contextualised, source-grounded guide to respectful adult obesity assessment, sustained health-focused care, and carefully governed escalation to medicines or metabolic surgery.
Summary
Obesity is chronic, multifactorial excess adiposity that can impair health, function and quality of life. It is not a character flaw and should not be reduced to a one-off instruction to eat less. Genetics, medicines, sleep, mental health, endocrine disease, disability, food environment, income, work pattern and past dieting all influence weight and the ability to change it. A respectful consultation asks permission to discuss weight, uses person-first language where preferred, and agrees goals that matter to the person: walking, sleep, pain, glucose, blood pressure, fertility, confidence or participation.
Body mass index (BMI) is a screening measure, not a full diagnosis of health. Measure height and weight accurately, consider waist-based assessment of central adiposity where appropriate, and interpret findings alongside cardiometabolic risk and comorbidity. The ICMR-NIN Dietary Guidelines for Indians note lower cardiometabolic-risk thresholds for Asian populations and emphasise that abdominal adiposity adds risk. [ICMR-NIN Dietary Guidelines for Indians 2024, obesity chapter.] Never treat a threshold as proof that two people have identical risk or should receive identical care.
Care is longitudinal. Assess the cause and complications; establish nutrition, activity, sleep and psychological support; and review change, barriers and adverse effects regularly. Current guidelines describes medicines as adjuncts after diet, physical-activity and behavioural approaches have started and been evaluated, with regular monitoring and wraparound support. [current guidelines, recommendations 1.17.1–1.17.6.] Metabolic surgery is not a quick cosmetic procedure: it requires specialist multidisciplinary assessment, informed consent, nutritional preparation and lifelong follow-up. [current guidelines, recommendations 1.18.1–1.18.17.]
How Common Is It?
Obesity affects populations worldwide and its prevalence has risen across age groups. WHO identifies obesity and overweight as major public-health concerns and links excess adiposity to diabetes, cardiovascular disease, musculoskeletal disease and some cancers. [WHO, Obesity and overweight fact sheet.] At the individual level, however, prevalence figures do not decide treatment. The consultation should identify current complications, trajectory, distress and barriers rather than imply that a person is unwell merely because they resemble a population statistic.
India faces a double burden: undernutrition and micronutrient deficiency coexist with overweight and obesity, sometimes in the same household. The ICMR-NIN guidance therefore places diet quality, dietary diversity and adequate nutrients alongside prevention of excess adiposity. [ICMR-NIN Dietary Guidelines for Indians 2024, Guidelines 1 and 9.] Poverty, food insecurity and time scarcity can lead to irregular meals and reliance on inexpensive energy-dense foods; an expensive imported diet plan is rarely a durable answer.
Avoid unsupported local prevalence claims in a clinical guide. Urban-rural patterns, availability of safe activity spaces, food prices, occupational activity and access to diabetes or obesity services differ between states and communities. It is more useful to record an individual baseline—weight trend, waist measure if used, blood pressure, function, metabolic risk and goals—and then reassess meaningful change over time.
Risk Factors
Risk is shaped by biology and context. Family history, genetic susceptibility, childhood weight trajectory, menopause, pregnancy-related weight change, inadequate sleep, chronic stress, depression, binge eating, disability, pain and reduced mobility may all contribute. Sedentary work and transport, screen-based leisure, irregular shifts, alcohol and diets high in highly processed foods or sugar-sweetened drinks can increase energy intake or reduce activity. These factors are assessment prompts, not grounds for blame.
Review medicines and timing. Glucocorticoids, some antipsychotics, selected antidepressants, some antiseizure medicines, insulin and sulfonylureas can contribute to weight gain in some people. Do not stop or change a medicine solely because of weight; involve the original prescriber and balance the indication, alternatives, relapse risk and metabolic effects. Consider hypothyroidism, Cushing syndrome, hypogonadism, polycystic ovary syndrome and rare genetic or hypothalamic causes only when history and examination make them plausible. Broad endocrine testing without clinical indication can mislead.
Risk assessment includes complications: type 2 diabetes, hypertension, dyslipidaemia, metabolic dysfunction-associated steatotic liver disease, obstructive sleep apnoea, osteoarthritis, reflux, infertility, pregnancy risks, depression, eating disorder and stigma-related avoidance of care. WHO and international guidelines both support whole-person assessment rather than a BMI-only response. [WHO fact sheet; current guidelines, general principles and assessment sections.]
Diagnosis
Diagnosis is a clinical assessment of adiposity-related risk, trajectory and complications, not a judgment based on appearance. Recheck unexpected measurements, explain what BMI can and cannot show, and agree which measures will be followed. Assess weight history, previous attempts, realistic goals and the social conditions that make change easier or harder.
History
Ask about onset and rate of change, childhood and family history, pregnancy or menopause where relevant, sleep, snoring, daytime sleepiness, activity limitation, diet pattern, sugary drinks, alcohol, shift work, mood, trauma, bingeing, purging and restrictive dieting. Review all prescribed, over-the-counter, herbal and online weight-loss products. Ask about diabetes symptoms, cardiovascular symptoms, reflux, joint pain, menstrual irregularity, sexual health and fertility goals. Screen sensitively for stigma, food insecurity and safety for physical activity.
Examination
Measure height, weight and blood pressure using validated equipment; calculate BMI and document the reference framework used. Consider waist assessment as an adjunct for central adiposity, taking privacy and cultural comfort seriously. Examine for acanthosis, oedema, features suggesting endocrine disease, hepatomegaly, joint or gait limitation and signs of sleep-disordered breathing risk. Do not infer an endocrine diagnosis from obesity alone.
Investigations
Select tests by risk: glucose or HbA1c, lipid profile, liver tests, renal function, blood pressure assessment and pregnancy testing where clinically relevant. Test thyroid function or cortisol only when symptoms or signs support the question. Sleep assessment, liver imaging, cardiovascular testing, eating-disorder assessment or specialist investigations should follow clinical findings and local pathways. Current guidelines recommends assessment that considers medical, nutritional, psychological and social needs before specialist surgery decisions. [current guidelines, recommendation 1.18.6.]
Differential Diagnosis
Differentiate excess adiposity from oedema, ascites, pregnancy, large fluid shifts, anabolic-muscle gain or measurement error. Heart, kidney and liver disease can increase body weight through fluid retention and need disease-directed assessment; diuretics are not weight-loss medicines. Review the timeline when weight changes rapidly after a new medicine, endocrine symptom or neurological event.
Most adult obesity is multifactorial. Endocrine causes are uncommon but important when there is reduced growth history, clear hypothyroid symptoms, proximal weakness with bruising or wide violaceous striae, galactorrhoea, hypogonadism, pituitary symptoms or a compatible medicine history. Polycystic ovary syndrome is assessed from reproductive and androgen features, not body size alone. Hypothalamic disease should be considered after a relevant tumour, surgery, irradiation or injury.
Eating disorders occur across the weight spectrum. Binge eating can contribute to distress and weight gain; purging, laxative use, severe restriction or compulsive exercise may coexist with a high BMI and make weight-focused advice unsafe. Depression, trauma, alcohol use and food insecurity need active care, not exclusion from obesity treatment. When a secondary cause is suspected, refer with the specific concern, documented history and examination rather than ordering indiscriminate panels.
Management
Start with shared, non-stigmatising goals and treat complications in parallel. A clinically meaningful outcome may be improved glucose, blood pressure, sleep, mobility, pain, fitness or quality of life even when weight change is modest. Avoid promising a particular percentage loss or a permanent outcome from any single intervention. Weight regain is common in a chronic condition and should lead to review and support, not blame.
Behavioural weight-management support combines nutrition, activity, sleep, problem-solving and follow-up. Build a food plan around locally available foods, culture, budget and skills: vegetables and fruit, pulses and beans, whole or less-refined grains, nuts or seeds where suitable, and appropriate dairy, eggs, fish or meat by preference. Reduce sugary drinks and frequent highly processed foods without labelling a whole regional cuisine as unhealthy. The ICMR-NIN guidance recommends dietary diversity, whole grains, pulses, vegetables and fruit, limiting foods high in sugar, salt or unhealthy fat, and regular physical activity. [ICMR-NIN Dietary Guidelines for Indians 2024, Guidelines 1, 3, 4, 5 and 9.]
Agree accessible activity that accounts for pain, disability, safety and time: walking, cycling, resistance work, household movement or supervised rehabilitation. Gradually increase activity and reduce prolonged sitting; do not prescribe an exercise target that puts an unconditioned person at injury risk. Address sleep apnoea, depression, anxiety, eating disorder, alcohol use and weight-promoting medicines concurrently. Refer to a dietitian, physiotherapist, psychologist, physician or specialist service when the required expertise is not available in primary care.
Medicines and surgery are escalation options within comprehensive care, not proof that lifestyle care has failed. Continue behavioural and nutrition support during and after either option. [current guidelines, medicines and surgery chapter.]
Prescribing Information
Do not use this guide as a dose chart or an online-product recommendation. Before any anti-obesity medicine, confirm the indication, age, BMI and comorbidity framework being used, pregnancy possibility, breastfeeding status, eating-disorder risk, pancreatitis or gallbladder history where relevant, renal/hepatic status, current diabetes medicines, contraindications, interactions and capacity for planned review. Verify the current Indian regulatory label, local formulary, supply route and specialist protocol; this guide makes no national availability, price or reimbursement claim.
Current guidelines lists orlistat, liraglutide, semaglutide and tirzepatide as adult medicine options only within medicine-specific criteria and alongside dietary, physical-activity and behavioural support. [current guidelines, Quality statement 6.] This does not establish that each product is authorised, appropriate or accessible in India. Product-specific titration, maximum dose, stopping rule, injection teaching and adverse-effect counselling belong to the current local product information and a prescriber experienced with the medicine. Do not extrapolate a diabetes product, compounded preparation or an internet-purchased injection to an obesity indication.
Review benefit, adherence, adverse effects, mood, nutrition, hydration and comorbidity treatment at planned intervals. When glucose-lowering treatment changes with weight loss, diabetes medicines may need adjustment to avoid hypoglycaemia; coordinate with the diabetes team. Current guidelines advises regular monitoring and reinforcement of behavioural advice, and support to maintain weight loss when a medicine is stopped. [current guidelines, recommendations 1.17.5–1.17.7.] Pregnancy and conception planning require medicine-specific review before starting, continuing or stopping treatment.
Do not prescribe thyroid hormone without hypothyroidism, diuretics or laxatives for weight loss, or unregulated herbal powders and fat burners. These can cause cardiac, metabolic, hepatic, psychiatric or nutritional harm. A request for a drug should open a shared risk-benefit discussion, not bypass assessment.
When to Refer
Refer to specialist weight-management, endocrinology or relevant medical services when obesity is severe or complicated, diagnostic uncertainty persists, intensive community support is insufficient, or pharmacotherapy or surgery is being considered. Refer earlier for suspected endocrine, genetic, hypothalamic or medication-related causes, significant liver disease, uncontrolled diabetes, difficult hypertension, severe osteoarthritis, fertility complexity or pregnancy planning.
A sleep service is appropriate for habitual loud snoring, witnessed apnoea, excessive daytime sleepiness, suspected obesity hypoventilation or high-risk driving. Mental-health or eating-disorder referral is urgent for suicidal thoughts, self-harm, purging, dangerous restriction, severe bingeing, trauma-related symptoms or substance dependence. Physiotherapy and rehabilitation can convert an unrealistic exercise prescription into an achievable mobility plan.
Surgery referral is an assessment, not a promise of an operation. Current guidelines advises adult referral for comprehensive multidisciplinary assessment at BMI 40 kg/m² or more, or 35–39.9 kg/m² with a significant condition that could improve with weight loss; it also advises considering a 2.5 kg/m² lower threshold for several ethnic groups including South Asian backgrounds. [current guidelines, recommendations 1.18.1–1.18.2.] These are UK recommendations, not Indian eligibility rules. An Indian centre must apply current local standards, clinical risk and access to lifelong follow-up.
Send weight trajectory, anthropometry method, blood pressure, comorbidities, laboratory data, medicine list, pregnancy status where relevant, eating and mental-health screen, previous interventions, functional limitations and the person's goals. This avoids repeating unsafe or ineffective care.
Red Flags
Urgently assess acute breathlessness, chest pain, syncope, confusion, severe hypertension symptoms, hypoxaemia, drowsy driving risk, or suspected obesity hypoventilation. Polyuria, polydipsia, vomiting, abdominal pain, dehydration, deep breathing or altered consciousness may indicate diabetes decompensation and requires prompt glucose and ketone assessment. Rapid weight gain with oedema, breathlessness or reduced urine output may be fluid retention rather than adiposity.
Promptly investigate features of a secondary disorder: rapid change with proximal muscle weakness, easy bruising and wide violaceous striae; new neurological symptoms; visual change; severe headaches; marked fatigue with other thyroid features; or hypothalamic disease history. New jaundice, persistent right-upper-quadrant pain or signs of advanced liver disease need appropriate evaluation.
Psychological red flags include suicidal thoughts, self-harm, severe depression, coercive weight control by others, bingeing with loss of control, vomiting, laxative misuse, prolonged fasting and compulsive exercise. An intervention aimed solely at weight may worsen an eating disorder. Commercial red flags include injections bought online, unlabelled compounds, aggressive detoxes, very-low-calorie regimens without supervision and claims of guaranteed rapid loss. Stop the unsafe product pathway, assess harm and provide non-judgemental medical review.
After any anti-obesity medicine or surgery, severe abdominal pain, persistent vomiting, dehydration, confusion, breathing difficulty or inability to maintain nutrition needs urgent clinical assessment according to the product or surgical pathway.
Indian Clinical Context
Indian practice should address abdominal adiposity and cardiometabolic risk while recognising the double burden of undernutrition and obesity. The ICMR-NIN Dietary Guidelines for Indians define adult Asian cut-offs in their obesity discussion and advise attention to waist circumference, diet quality and physical activity. [ICMR-NIN Dietary Guidelines for Indians 2024, obesity chapter.] Record the measure and reference used rather than presenting a cut-off as a diagnosis in isolation.
Food counselling should be practical and culturally safe. Diverse affordable meals can use pulses, beans, vegetables, seasonal fruit, whole or less-refined grains, curd or other dairy, eggs, fish and meat according to preference and resources. Review sweetened beverages, fried snacks, packaged foods, delivery meals and portion patterns without portraying rice, roti or any community food as inherently harmful. Food insecurity may require social support and an achievable meal structure before calorie restriction is discussed.
Access to dietitians, psychologists, sleep studies, obesity medicines, metabolic surgery, follow-up laboratories and emergency care varies substantially by city, state, insurer and facility. Do not state that a medicine is available, affordable, licensed or reimbursed nationally without checking the current Indian regulator, formulary and local service. This guide therefore names treatment classes and safeguards, not market claims or doses. Where specialist care is distant, use a documented review date, management of comorbidities and a clear referral route instead of serial unmonitored escalation.
Weight stigma can delay care and worsen mental health. Use privacy, consent and respectful language; avoid public weighing, punitive exercise or making access to unrelated care conditional on weight loss.
NMC Competency Mapping
This guide integrates Medicine, Endocrinology, Pharmacology, Nutrition, Psychiatry, Community Medicine, Surgery and AETCOM. Learners should explain multifactorial causation, calculate and interpret BMI within the declared reference framework, assess central adiposity as an adjunct, identify common complications and recognise when the clinical pattern suggests a secondary cause. The NMC CBME Curriculum 2024 is the source for current institutional mapping; exact competency codes and certification requirements should be checked in the local curriculum record. [NMC CBME Curriculum 2024, compendium.]
At Know and Know How level, a student should take a non-stigmatising diet, activity, sleep, medicine and psychosocial history; examine blood pressure and cardiometabolic clues; choose targeted tests; and propose a realistic longitudinal plan. At Show How level, assessment can require motivational, culturally responsive counselling and a safe referral letter rather than an unsupported dose prescription.
Pharmacology teaching should distinguish class awareness from independent prescribing. Before discussing a medicine, learners should perform a pregnancy, comorbidity, interaction, diabetes-treatment and monitoring check, locate the current label or formulary, and explain why market availability cannot be assumed. Surgical teaching should emphasise multidisciplinary assessment, consent, nutritional support and lifelong follow-up. These safeguards matter as much as recalling procedure names.
Key Exam Pearls for NEET PG
Obesity is chronic and multifactorial; assess health impact, function and comorbidity rather than treating BMI as the whole diagnosis. BMI is weight in kilograms divided by height in metres squared, but it is a screening measure. In South Asian clinical contexts, lower cardiometabolic-risk thresholds and central adiposity are important; state the reference standard used. [ICMR-NIN Dietary Guidelines for Indians 2024, obesity chapter.]
History should include weight trajectory, medicines, sleep-apnoea symptoms, dietary pattern, activity, alcohol, mood and eating disorder. Measure blood pressure and assess diabetes, dyslipidaemia, liver disease, sleep apnoea, osteoarthritis, reproductive health and psychological distress. Endocrine testing is directed by compatible symptoms or signs; common multifactorial obesity does not itself diagnose hypothyroidism or Cushing syndrome.
Long-term management combines nutrition, activity, behavioural support and treatment of comorbidities. Anti-obesity medicines are adjuncts with product-specific eligibility, contraindications, titration and monitoring, not a substitute for comprehensive care. Do not quote a dose from memory or make India availability claims; verify the current Indian label and specialist protocol. [current guidelines, recommendations 1.17.1–1.17.7.]
Metabolic surgery is assessed by a specialist multidisciplinary team with psychological, nutritional and surgical expertise and lifelong follow-up. current guidelines' BMI referral criteria are jurisdiction-specific and cannot be substituted for local Indian policy. [current guidelines, recommendations 1.18.1–1.18.17.] Red flags include acute diabetes symptoms, respiratory compromise, severe mental-health risk, suspected secondary disease and unsafe online or compounded weight-loss products.
Frequently Asked Questions
Is obesity management only about losing a certain number of kilograms?
No. Weight can be followed, but management should also target health and function: blood pressure, glucose, sleep, mobility, pain, mood, fertility goals and ability to participate in daily life. Agreeing a meaningful goal reduces stigma and makes review more useful. A lack of rapid weight change should trigger review of barriers and safety, not blame or abandonment of care.
Should every adult with obesity have extensive hormone testing?
No. Most adult obesity is multifactorial. Thyroid, cortisol, reproductive or other endocrine tests are selected when history or examination supports a specific concern, such as compatible symptoms, physical signs or a relevant medicine or neurological history. Broad testing can produce incidental results and delay attention to common complications such as diabetes, hypertension, sleep apnoea and liver disease.
Can anti-obesity medicines be bought online and used without follow-up?
No. A medicine requires a verified current indication, contraindication and interaction check, pregnancy and diabetes-treatment review, counselling and planned monitoring. Online, compounded or imported products can have uncertain provenance and may not match a locally authorised obesity indication. Product-specific titration and stopping decisions must come from current Indian information and an appropriate prescriber or specialist service.
Does a bariatric surgery referral mean surgery will definitely happen?
No. Referral begins a comprehensive multidisciplinary assessment of medical, nutritional, psychological, social and surgical factors. It should clarify benefits, risks, alternatives, capacity for lifelong follow-up and the person's own goals. A person may instead need more intensive non-surgical support, treatment of an eating disorder or comorbidity, or a different service. Referral is an informed assessment pathway, not a commitment.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic